ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RAPT RAPT Therapeutics Inc

4.36
-0.30 (-6.44%)
May 10 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
RAPT Therapeutics Inc RAPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.30 -6.44% 4.36 19:59:55
Open Price Low Price High Price Close Price Prev Close
4.54 4.18 4.63 4.33 4.66
more quote information »

Recent News

Date Time Source Heading
5/09/202408:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202408:03EDGAR2Form 8-K - Current report
5/09/202408:00GLOBERAPT Therapeutics Reports First Quarter 2024 Financial..
4/09/202412:00GLOBERAPT Therapeutics Announces Promising Results from Phase 2..
3/07/202416:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/07/202408:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/202408:03EDGAR2Form 8-K - Current report
3/07/202408:00GLOBERAPT Therapeutics Reports Fourth Quarter and Full Year 2023..
3/05/202416:30GLOBERAPT Therapeutics Announces Multiple Late-Breaking..
2/22/202417:13EDGAR2Form 8-K - Current report
2/20/202416:29EDGAR2Form 8-K - Current report
2/20/202407:30GLOBERAPT Therapeutics Announces Clinical Hold on Studies..
2/14/202408:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202408:00GLOBERAPT Therapeutics Bolsters Leadership Team with the..
1/31/202408:00GLOBERAPT Therapeutics to Participate in the Guggenheim..
1/02/202408:00GLOBERAPT Therapeutics to Present at the 42nd Annual J.P. Morgan..
11/27/202308:00GLOBERAPT Therapeutics Announces Publication of Phase 1a/1b..
11/13/202308:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202308:03EDGAR2Form 8-K - Current report
11/13/202308:00GLOBERAPT Therapeutics Reports Third Quarter 2023 Financial..
11/03/202312:03EDGAR2Form 8-K - Current report
11/03/202312:00GLOBERAPT Therapeutics Announces Positive Data, Including..
11/01/202316:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
10/18/202309:00GLOBERAPT Therapeutics Announces Two FLX475 Presentations at the..
8/30/202316:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
8/18/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/11/202316:02EDGAR2Form 8-K - Current report
8/11/202308:57EDGAR2Form S-3 - Registration statement under Securities Act of..
8/11/202308:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/202308:05EDGAR2Form 8-K - Current report
8/11/202308:00GLOBERAPT Therapeutics Reports Second Quarter 2023 Financial..
6/07/202308:00GLOBERAPT Therapeutics to Participate in the Goldman Sachs Global..
5/25/202317:00GLOBERAPT Therapeutics to Present Biomarker Data Corroborating..

Your Recent History

Delayed Upgrade Clock